- $26.49m
- $25.06m
- $3.20m
- 45
- 27
- 41
- 31
Annual income statement for ACMAT, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Total Premiums Earned | |||||
| Net Investment Income | |||||
| Realized & Unrealized Gains / Losses | |||||
| Total Revenue | 3.02 | 3.31 | 0.466 | 2.15 | 3.2 |
| Losses, Benefits, and Adjustments | |||||
| Amortization of Policy Acquisition Costs | |||||
| Selling / General / Administrative Expenses | |||||
| Total Operating Expenses | 2.09 | 1.74 | 2.51 | 1.74 | 2.86 |
| Operating Profit | 0.932 | 1.57 | -2.04 | 0.405 | 0.341 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 0.857 | 1.5 | -2.11 | 0.377 | 0.319 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.696 | 1.21 | -1.85 | 0.51 | 0.239 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.696 | 1.21 | -1.85 | 0.51 | 0.239 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.696 | 1.21 | -1.85 | 0.51 | 0.239 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.89 | 1.57 | -2.4 | 0.661 | 0.31 |